Weaver C. Barksdale & Associates’s Eastman Chemical EMN Stock Holding History
Bought
Maintained
Sold
Other funds holding EMN
Weaver C. Barksdale & Associates's EMN Position: Q2 2026 in Review
Weaver C. Barksdale & Associates reduced its Eastman Chemical (EMN) stake by 0.11% in Q2 2026, selling an estimated $951 and leaving 11,884 shares worth $796K. The position accounts for 0.71% of the portfolio, ranked #60.
Weaver C. Barksdale & Associates first reported a position in EMN in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.02M in Q4 2021. 645 funds tracked by Wall St. Rank hold EMN as of Q2 2026.
- Weaver C. Barksdale & Associates held 11,884 shares of Eastman Chemical worth $796K as of Q2 2026.
- Weaver C. Barksdale & Associates sold 13 Eastman Chemical shares in Q2 2026, an estimated $951.
- Eastman Chemical made up 0.71% of Weaver C. Barksdale & Associates's portfolio in Q2 2026, its #60 holding.
- Weaver C. Barksdale & Associates first reported a position in Eastman Chemical in Q4 2021 and has held it in 19 quarters since.
- Weaver C. Barksdale & Associates's Eastman Chemical position peaked at $2.02M in Q4 2021.
- 645 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.
Based on Weaver C. Barksdale & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.